
Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …

Shares in CytRx (Nasdaq: CYTR) lost nearly three-fourth in value after the company reported disappointing late-stage results for its lead …

Drug trial results remained the important theme over the past week with several companies announcing key study results. The trial …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

